ライフサイエンスコーパス: general practice

1 ED visits by the registered population of a general practice.

2 y before these results are incorporated into general practice.

3 uch medication related potential for harm in general practice.

4 d omeprazole (20 mg/day) on GERD symptoms in general practice.

5 mary prevention and early diagnosis of HF in general practice.

6 ex-matched controls without ITP recruited in general practice.

7 nce in the electronic medical records of the general practice.

8 caries-free children aged 2 to 3 y attending general practice.

9 01 with up to five controls by age, sex, and general practice.

10 patients without psoriasis on age, sex, and general practice.

11 treatments are not routinely implemented in general practice.

12 Controls were matched on age, sex, and general practice.

13 mentia diagnosis and patient presentation to general practice.

14 s great scope for improved management within general practice.

15 story of seizures, matched for age, sex, and general practice.

16 that there is little monitoring of deaths in general practice.

17 jects, individually matched by age, sex, and general practice.

18 d one of the more common ones encountered in general practice.

19 naire being developed as a screening tool in general practice.

20 patient-facing clinical workload in English general practice.

21 for general practitioner consultations in UK general practice.

22 Both groups were stratified by general practice.

23 ns will encounter children with IBD in their general practice.

24 ajority (54%) of the patients were tested in general practice.

25 es are required to allow recommendations for general practice.

26 nce was computer-generated and stratified by general practice.

27 een 2 and 21 years' experience of working in general practice.

28 [ICD]-10 criteria for depression) from 73 UK general practices.

29 This laboratory serves four hospitals and 75 general practices.

30 o all adults age >30 years registered with 2 general practices.

31 dividuals by post using age-sex registers of general practices.

32 ts were aged 16-50 yr and registered with 40 general practices.

33 They came from 16 randomly selected general practices.

34 omised controlled trial involving 45 English general practices.

35 igibility and recruited 424 patients from 95 general practices.

36 nary heart disease Registers in South London General Practices.

37 om 49 intervention (n=23) and control (n=26) general practices; 149 participants per group comprised

38 at one of 2 Melbourne, Victoria, Australia, general practices (2007-2013).

39 .4%; internal medicine, 27.5%; and family or general practice, 21.1%).

40 a cluster-randomised factorial trial in 106 general practices (43219 eligible patients aged 75 years

41 iated with increased visits to physicians in general practice (6.6 percentage points [CI, 1.3 to 12.0

42 ealth providers and patients from Australian general practice, Aboriginal community-controlled and go

43 Using 2012 and 2013 QOF data from 9731 general practices across all four countries in the UK, w

44 holds data from 753 National Health Service general practices across England.

45 a computerized primary care database of 177 general practices across the United Kingdom; 8778 cases

46 Participants were recruited by post from general practice age-sex registers and subsequently comp

47 40 of 45 (89%) general practices agreed to participate: 20 were assigne

48 Stricter targets in general practice and further measures to motivate patien

49 Authorities, Department of Health, academia, General Practice and Hospital Trusts and the third secto

50 Hospital, general practice and laboratory records were searched to

51 A general practice and public health perspective favors th

52 r the previous year; visits to physicians in general practice and specialists; hospitalizations and e

53 ethotrexate is a commonly prescribed drug in general practice and when used in NMO it reduces relapse

54 HCPs (doctors/nurses in general practice and/or hospital) were regarded by patie

55 15 general practices and 7012 patients receiving the nurse

56 regression to account for clustering within general practices and adjusting for other key variables.

57 General practices and community clinics were randomised

58 effectiveness (cost-utility) trial across 27 general practices and community musculoskeletal services

59 D3 supplementation in adults with COPD in 60 general practices and four Acute National Health Service

60 eople aged over 40, who were registered with general practices and had been exposed to the death of a

61 ) were identified from medical records in 99 general practices and invited to participate by their ge

62 chronic low-back pain were recruited from 56 general practices and received an active management advi

63 es > or =50 years who were registered with 3 general practices and were experiencing knee pain within

64 rolled trials were conducted at 53 hospital, general practice, and academic centers in the United Sta

65 ioverter-defibrillator (ICD) implantation in general practice, and estimate the incremental costs of

66 of 12, with stratification by trial centre, general practice, and household type.

67 locks of 12, and stratified by trial centre, general practice, and household type.

68 0 controls matched to the cases by age, sex, general practice, and time in the cohort were selected.

69 ,025 controls matched by year of birth, sex, general practice, and years of medical records before th

70 ek follow-up at 100 sites (hospital clinics, general practices, and clinical research centers) in 14

71 ments and investigated the risk of missing a general practice appointment using a negative binomial m

72 Individual-level patterns of missed general practice appointments might thus provide a risk

73 racteristics contribute to non-attendance of general practice appointments raise important questions

74 ractice factors to the likelihood of missing general practice appointments.

75 Clinical scoring systems that may be used in general practice as initial screening tools also may pro

76 nd cause of death and registered at the same general practices as those with intellectual disabilitie

77 burden of work for physicians and nurses in general practice associated with newly diagnosed dementi

78 We recruited 22 general practices (August 2013-September 2014) and 13 co

79 CC3 genotype was investigated using PCR in a general-practice-based sample of 565 women and 475 patie

80 isorder while registered with a contributing general practice between 1987 and 2001.

81 temporary patients registered at 398 English general practices between April, 2007, and March, 2014.

82 There is growing concern that many general practices cannot respond to new expectations.

83 s, which are accessible by all hospitals and general practices caring for coronary and high-risk pati

84 A prospective study conducted in a Thai general practice clinic demonstrated a high prevalence (

85 ontrolled, two-arm effectiveness trial at 74 general practice clinics in Salford and South Manchester

86 r diabetes or family history registers at 20 general practice clinics in the UK.

87 We randomly allocated 36 general practice clusters from the West Midlands health

88 In a large general-practice cohort of patients with multiple cardio

89 nts registered between 1990 and 2008 at U.K. general practices contributing to The Health Improvement

90 ses and symptoms were calculated from 361 UK general practices contributing to The Health Improvement

91 ith individuals without BE for age, sex, and general practice (controls, N = 155,212).

92 ged less than 45 years randomly sampled from general practices countrywide.

93 gic Research, Danish Research Foundation for General Practice, Danish Centre for Evaluation and Healt

94 sis, we extracted UK National Health Service general practice data that were routinely collected acro

95 ovement Network, a large population-based UK general practice database, were used to conduct a matche

96 cataract-free controls matched on age, sex, general practice, date of cataract recording (i.e., inde

97 igate the extent to which periodontists' and general practice dentists' (GPs) behaviors and attitudes

98 Five UK General practices each sent the PFSDQ2 by post to 2000 p

99 bing people's stories; trial 3 (June, 2013), general practice endorsement of the programme on the inv

100 isk scoring methods are to be widely used in general practice, evidence is required on both the accur

101 ged >/=65 years with dementia in 87 Scottish general practices, examining the impact of two pre-speci

102 ith type 2 diabetes registered with enrolled general practices (except those who were attending an op

103 ex date), matched by year of birth, sex, and general practice for a control to case ratio of 4 to 1.

104 tics linkage, and were registered with their general practice for at least 12 months.

105 er allergy assessment and tailored advice in general practice for patients with asthma and rhinitis e

106 indicators were examined using data from 76 general practices for 2009-2010 in a large primary care

107 rally sensitive, enhanced care package in UK general practices for improvement of cardiovascular risk

108 ed >/=35 years and matched for sex, age, and general practice from the United Kingdom Clinical Practi

109 al medicine, pediatrics, family practice, or general practice) from those groups and affiliated with

110 solated from patients registered to the same general practice (GP) surgery.

111 Using data from GUM clinics and a sample of general practices (GPs) throughout England, we analyzed

112 Health professionals from general practices (GPs) who signed up to LES were given

113 according to baseline BDI score, whether the general practice had a counsellor, previous treatment wi

114 Our cohort of 1,958,191 people from UK general practices had a median age at baseline of 55 yea

115 ypes of bariatric surgery based on data from general practice has not been carried out.

116 ibular rehabilitation delivered by nurses in general practice improves symptoms, postural stability,

117 lts, we designed a clinical flow diagram for general practice in detecting recurrent MTC.

118 ears) who were permanently registered with a general practice in three defined geographical areas (Ca

119 creening of 7735 men 40 to 59 years old from general practices in 24 British towns, 4252 subjects (77

120 (Q1) of 7735 men 40 to 59 years of age from general practices in 24 British towns, 5934 (91% of avai

121 (Q1), 7735 men aged 40-59 were selected from general practices in 24 British towns, and enrolled in a

122 stroke, or diabetes and who were drawn from general practices in 24 British towns.

123 ase, stroke, or diabetes who were drawn from general practices in 24 British towns.

124 cular disease and cancer and were drawn from general practices in 24 British towns.

125 study at hospitals, minor injury units, and general practices in and around 4 UK study centers.

126 recommend implementation of HIV screening in general practices in areas with high HIV prevalence.

127 agnosis of depression were recruited from 55 general practices in Bristol, London, and Warwickshire,

128 parallel group, cluster-randomised trial, 33 general practices in eastern England were randomly assig

129 ly selected from the age-sex registers of 11 general practices in Edinburgh, Scotland, and followed u

130 years without CRC were identified from three General Practices in England (two in Cumbria, one in Lon

131 tively healthy adults, aged 70-79 y, from 20 general practices in England and Wales were randomly ass

132 without radiculopathy) consultations at ten general practices in England responded to invitations to

133 d analysis of patients registered with 7,856 general practices in England was conducted, for the time

134 lly from clinical computing systems for 7637 general practices in England, data from the UK census, a

135 ing a household by mailed invitation through general practices in England.

136 f 2-8 weeks' duration were recruited from 25 general practices in England.

137 Simple 1:1 randomization of general practices in Germany was used.

138 We randomised 51 (61%) of 84 eligible general practices in Hackney and Bristol.

139 trial, we randomised 50 of 52 (96%) eligible general practices in Hackney, London, UK, to receive an

140 ction and the effect of screening for HIV in general practices in Hackney.

141 28,080 individuals aged 35 and over from 40 general practices in inner-city, urban, and rural areas

142 We screened computerised records of 15 general practices in London, UK, for patients with speci

143 ic registers from a representative sample of general practices in Newcastle upon Tyne.

144 duals (age > or =50 years) registered with 3 general practices in North Staffordshire in the UK.

145 nd, randomised controlled trial, we included general practices in Scotland, UK.

146 RTIs among children aged 0-12 years from all general practices in the Clinical Practice Research Data

147 atients, aged 25 and over, was drawn from 29 general practices in the Grampian region of the UK and s

148 In general practices in the intervention groups, angiotensi

149 n an unselected urban population based in 13 general practices in the London area by a General Practi

150 12 General Practices in the Northwest of England located wi

151 We used data from general practices in the UK (General Practice Research D

152 ta covering the entire Danish population and general practices in the UK Clinical Practice Research D

153 financial incentive scheme that remunerates general practices in the UK for their performance agains

154 In this pragmatic, cluster randomised trial general practices in the UK were stratified by research

155 ing individuals of all ages who presented to general practices in the UK with influenza-like illnesse

156 trolled trial, we recruited patients from 34 general practices in the UK.

157 omised controlled trial was undertaken in 24 general practices in the UK.

158 rom a population of 253,618 patients from 42 general practices in the UK.

159 8 years and over and were recruited from 115 general practices in the UK.

160 More than 650 general practices in the United Kingdom contributing to

161 case-control study was conducted within 454 general practices in the United Kingdom using the QRESEA

162 f consecutive back pain consulters from five general practices in the United Kingdom was carried out

163 r-randomised controlled trial, participating general practices in the West Midlands, UK, were randoml

164 ividuals aged at least 40 years attending 26 general practices in three areas of England between Dec

165 ed trial with participants recruited from 43 general practices in three areas of England.

166 a randomised controlled trial done across 73 general practices in three UK centres.

167 ter randomised controlled trial, we selected general practices in two urban primary care trusts, Hack

168 intenance antidepressants, from primary care general practices in urban and rural settings in the UK.

169 mending adoption of lung cancer screening in general practice is premature.

170 However, regardless of stage, general practice is to treat patients based on limited (

171 Promotion of opt-out rapid testing in general practice led to increased rate of diagnosis, and

172 Our Liaison and Education in General Practices (LEGs) study was a cluster-randomised

173 13 general practices in the London area by a General Practice Linkage Scheme with the National Hospit

174 General practice, long considered the jewel in the crown

175 in both modes demonstrate that, contrary to general practice, negative mode allows better sensitivit

176 asing incidence that is commonly seen in the general practice of nephrology.

177 s (alive and registered with a participating general practice on 24 September 2009).

178 ber of persons registered with participating general practices on that same date.

179 atasets (Clinical Practice Research Datalink General Practice OnLine Database linked with Hospital Ep

180 d data from 796,594 population-based English General Practice Patient Survey responders to explore th

181 t 5 years was more commonly reported by male General Practice Patient Survey responders who endorsed

182 The allocation was not masked to general practices, pharmacists, patients, or researchers

183 Before using this regimen in general practice, phase III clinical trials should be co

184 ospective survey of specimens submitted from general practice, private specialists, and hospitals to

185 General practices provided lists of individuals to be co

186 General practices providing more timely access to primar

187 ter-randomised controlled trial including 43 general practices randomised to receive either standard

188 nd lifestyle were obtained by questionnaire, general practice records, and patient interview.

189 and GORD in menopausal women using validated general practice records.

190 questionnaires and computerised and written general-practice records, and its effect on bone-mineral

191 alth services was assessed from hospital and general-practice records.

192 was composed using primary care records from general practice registration networks (GPRNs) across th

193 orectal cancer-free initial follow-up in the General Practice Research Database (1987-2002) from the

194 d case-control study was conducted using the General Practice Research Database (1987-2003), which co

195 s claims database) from 1998-2002 and the UK General Practice Research Database (GPRD) between 1990-2

196 multiple sclerosis diagnosis recorded in the General Practice Research Database (GPRD) between Januar

197 The UK General Practice Research Database (GPRD) contains the c

198 is is a retrospective cohort study using the General Practice Research Database (GPRD) from the Unite

199 32,973 matched controls, extracted from the General Practice Research Database (GPRD) over the perio

200 The United Kingdom General Practice Research Database (GPRD) was used to id

201 The study was carried out in the General Practice Research Database (GPRD), a primary car

202 ish Hospital Episodes Statistics (HES) data, General Practice Research Database (GPRD), and Office of

203 The study was based on the UK General Practice Research Database (GPRD), which covers

204 controls identified from 1990 to 2005 in the General Practice Research Database (GPRD).

205 with data from Jan 1, 1990 to Dec 31, 2009 (General Practice Research Database and Optimum Patient C

206 e patient's medical record and stored in the General Practice Research Database between 1987 and 2002

207 enopausal women were identified using the UK General Practice Research Database between 1995-2004.

208 omen with asthma were identified from the UK General Practice Research Database between 2000 and 2008

209 rol study nested in the United Kingdom-based General Practice Research Database cohort, the authors i

210 We identified all individuals in the UK General Practice Research Database diagnosed with esopha

211 e, for whom there were data available in the General Practice Research Database for 1989 to 1999 in E

212 enzalike illness using cases recorded in the General Practice Research Database from 1990 to 2005 in

213 h type 2 diabetes were generated from the UK General Practice Research Database from November 1986 to

214 diagnosis of type 2 diabetes mellitus in the General Practice Research Database from the United Kingd

215 d case-control analysis was conducted on the General Practice Research Database from the United KINGD

216 y general practitioners participating in the General Practice Research Database in the United Kingdom

217 cases identified during 1990-2001 using the General Practice Research Database in the United Kingdom

218 esigns free of any immortal time bias in the General Practice Research Database in the United Kingdom

219 ucted a retrospective cohort study using the General Practice Research Database in the United Kingdom

220 Data were obtained from the UK General Practice Research Database on 4709 individuals w

221 UK General Practice Research Database Pregnancies ending in

222 We used the General Practice Research Database to ascertain the inci

223 Data were extracted from the UK General Practice Research Database to compare the incide

224 We used 1988 to 1997 data from the General Practice Research Database to conduct a retrospe

225 We have used the General Practice Research Database to perform a case-con

226 We have performed a cohort study using the General Practice Research Database to quantify the exces

227 a population-based cohort study by using the General Practice Research Database to quantify the fract

228 All patients in the UK General Practice Research Database undergoing a THR for

229 The General Practice Research database was analyzed to ident

230 The General Practice Research Database was used to identify

231 We selected subjects within the General Practice Research Database with a coded diagnosi

232 nt records from a primary care database (the General Practice Research Database) was carried out for

233 used data from general practices in the UK (General Practice Research Database).

234 using computerized medical records from the General Practice Research Database, a large representati

235 was derived from the England and Wales-based General Practice Research Database, composed of 3.5 mill

236 nts with RA ages >or=40 years in the British General Practice Research Database, each matched by age,

237 Among patients in the UK General Practice Research Database, the use of oral bisp

238 cohort studies, utilizing the United Kingdom General Practice Research Database, to assess intraindiv

239 Using the General Practice Research Database, we estimate the inci

240 690 children, derived from the West Midlands General Practice Research Database, we investigated a nu

241 From the General Practice Research Database, we matched patients

242 control study using the United Kingdom-based General Practice Research Database, we tested the hypoth

243 The study was based on the United Kingdom General Practice Research Database, which contains compu

244 iagnoses of HD, were retrieved from the UK's General Practice Research Database.

245 76) in 1999 and 2007 were extracted from the General Practice Research Database.

246 tudinal cohort study was conducted in the UK General Practice Research Database.

247 and 2007 (n=13 330) were extracted from the General Practice Research Database.

248 Data were drawn from the UK General Practice Research Database.

249 ial Ischaemia National Audit Project and the General Practice Research Database.

250 m 197 family practices in the United Kingdom General Practice Research Database.

251 of lymphoma in psoriasis patients using the General Practice Research Database.

252 ional study using 1988 to 1997 data from the General Practice Research Database.

253 id a matched case-control study using the UK General Practice Research Database.

254 9,889 controls drawn from the United Kingdom General Practice Research Database.

255 ormed a retrospective cohort study using the General Practice Research Database.

256 8 practices which contribute to the UK-based General Practice Research Database.

257 ntrol subjects drawn from the United Kingdom General Practice Research Database.

258 January 2000 through November 2009 using the General Practice Research Database.

259 rs when designing future trials and refining general practice screening guidelines.

260 were measures of patient-reported access to general practice services; these were entered into a neg

261 is of melanoma occurred more frequently in a general practice setting and less frequently in direct c

262 patients without a history of epilepsy in a general practice setting using Clinical Practice Researc

263 atment of nonvalvular atrial fibrillation in general practice settings has not been established.

264 In general practice settings, dabigatran was associated wit

265 internal medicine specialists and family or general practice specialists were more likely to have gu

266 OR], 0.86 per decade; 95% CI, 0.79-0.94) and general practice specialty (OR, 1.54 compared with famil

267 randomised controlled trial was delivered to general practice staff.

268 The National General Practice Study of Epilepsy and other studies hav

269 The National General Practice Study of Epilepsy is a prospective stud

270 The UK National General Practice Study of Epilepsy is a prospective, pop

271 ies and focuses particularly on the National General Practice Study of Epilepsy, a prospective popula

272 iagnosis and management of asthma and define general practices that meet the needs of most patients.

273 essages in six radiology departments and 244 general practices that they served.

274 cases and 2,193 poisoning cases, matched on general practice to 94,620 control children.

275 aper could be cost-effectively extended into general practice to reduce smoking and smoking-related i

276 Why has the transition from general practice to today's primary care been so difficu

277 ied and matched on age, diabetes status, and general practice to up to four unexposed controls.

278 mber, 2011, we randomly assigned (1:1) these general practices to either health checks plus standard

279 introduction of health insurance systems or general practice, took into account political issues mor

280 computerized morbidity indices of 2 large UK general practices, total population 22,500.

281 ntrols to each case patient by age, sex, and general practice (United Kingdom only) using risk-set sa

282 s in the first 2000 US patients implanted in general practice use.

283 r patient 'same-day' appointment requests in general practice using multivariable logistic regression

284 o $90), more than 15% higher than that for a general practice visit in the Philadelphia region.

285 0 230 patients registered with participating general practices was followed prospectively for the ons

286 From 22 general practices, we identified patients with recently

287 ntrolled effectiveness trial conducted in 75 general practices, we randomly assigned 2799 patients wi

288 ies, six pairs of hospitals and six pairs of general practices were assigned to an intervention progr

289 atients aged 40-89 years registered with 205 general practices were followed from 2003-2007.

290 ed controlled trial in Hackney (London, UK), general practices were randomly assigned (1:1) to offer

291 14, 74 818 eligible patients from 54 diverse general practices were randomly assigned and completed t

292 in Denmark, the Netherlands, and the UK, 343 general practices were randomly assigned screening of re

293 (date of the first diagnosed fracture), and general practice, were randomly selected for each case.

294 Data were obtained from records from general practices who had registered patients with the U

295 ntral web-based system and was stratified by general practice with minimisation for sex, baseline sys

296 FINDINGS: 72 general practices with a combined list size of 480,942 p

297 osen at the time of psoriasis diagnosis from general practices with at least one case, excluding chil

298 for reducing a range of medication errors in general practices with computerised clinical records.

299 Set in 13 general practices within central England.

300 ion programme promoting rapid HIV testing in general practice would lead to increased and earlier HIV